Pfizer expanded its cost-cutting ... program resulting from the Inflation Reduction Act will hurt sales by $1 billion, dampening growth by approximately 1.6% compared with 2024. Stripping out ...

Pfizer is raising the ... Of that total, $4.5 billion in net cost savings will be realized by the end of this year from an ongoing cost-realignment program, the company said in its first-quarter ...

Pfizer adds the guidance does not include the potential impact of future changes in trade and tariff policies. Cost-Cutting Initiatives ... With the new target, total program savings are expected ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it ...

Pfizer on Tuesday reaffirmed its outlook for the year, and announced another round of cost cuts as the beleaguered drugmaker looks to turn around its business postpandemic. The company forecast ...